Sign in

CIK 0001672619

  • Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811523849
Phone
+1 650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,585,364
in 5 filings, $979K under 10b5-1 plans

Net −$1,585,364. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-22 GRAY MICHAEL CFO & COO Sale −9,856 $4.67 $46K 27,610
2023-01-30 GRAY MICHAEL CFO & COO Sale −3,596 $3.92 $14K 37,466
2022-01-28 GRAY MICHAEL CFO & COO Grant or award +39,350 42,312
2022-01-28 GRAY MICHAEL CFO & COO Grant or award · Stock Option (right to buy) +39,350 39,350
2021-01-26 GRAY MICHAEL CFO & COO Grant or award · Stock Option (right to buy) +60,800 60,800
2020-12-11 GRAY MICHAEL CFO & COO Exercise or conversion +1,250 $4.92 $6K 1,250
2020-12-11 GRAY MICHAEL CFO & COO Sale −1,250 $25.00 $31K 0
2020-12-11 GRAY MICHAEL CFO & COO Exercise or conversion · Stock Option (Right to Buy) −1,250 223,059

Page 1 of 1 · 8 trades